Clinical Trial Update: Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular Edema [Phase 1, Phase 2]

View source ↗

Summary

A pilot Phase 1/2 clinical trial is evaluating intravitreal infliximab for the treatment of diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Infliximab (Remicade) (Infliximab)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Diabetic Macular Edema | Phase 1, Phase 2 | Status: UNKNOWN